ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2011

The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Anjaiah Srirangam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.